CGC
Price
$1.14
Change
+$0.03 (+2.70%)
Updated
Jul 25 closing price
Capitalization
784.64M
12 days until earnings call
TEVA
Price
$16.54
Change
+$0.21 (+1.29%)
Updated
Jul 25 closing price
Capitalization
15.06B
3 days until earnings call
Interact to see
Advertisement

CGC vs TEVA

Header iconCGC vs TEVA Comparison
Open Charts CGC vs TEVABanner chart's image
Canopy Growth
Price$1.14
Change+$0.03 (+2.70%)
Volume$6.43M
Capitalization784.64M
Teva Pharmaceutical Industries
Price$16.54
Change+$0.21 (+1.29%)
Volume$9.21M
Capitalization15.06B
CGC vs TEVA Comparison Chart in %
Loading...
CGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TEVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGC vs. TEVA commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGC is a StrongBuy and TEVA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (CGC: $1.14 vs. TEVA: $16.54)
Brand notoriety: CGC and TEVA are both notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CGC: 67% vs. TEVA: 89%
Market capitalization -- CGC: $784.64M vs. TEVA: $15.06B
CGC [@Pharmaceuticals: Other] is valued at $784.64M. TEVA’s [@Pharmaceuticals: Other] market capitalization is $15.06B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGC’s FA Score shows that 0 FA rating(s) are green whileTEVA’s FA Score has 1 green FA rating(s).

  • CGC’s FA Score: 0 green, 5 red.
  • TEVA’s FA Score: 1 green, 4 red.
According to our system of comparison, TEVA is a better buy in the long-term than CGC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGC’s TA Score shows that 5 TA indicator(s) are bullish while TEVA’s TA Score has 3 bullish TA indicator(s).

  • CGC’s TA Score: 5 bullish, 3 bearish.
  • TEVA’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, CGC is a better buy in the short-term than TEVA.

Price Growth

CGC (@Pharmaceuticals: Other) experienced а +4.59% price change this week, while TEVA (@Pharmaceuticals: Other) price change was +2.99% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.53%. For the same industry, the average monthly price growth was +11.98%, and the average quarterly price growth was +75.52%.

Reported Earning Dates

CGC is expected to report earnings on Nov 07, 2025.

TEVA is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+3.53% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TEVA($15.1B) has a higher market cap than CGC($785M). TEVA YTD gains are higher at: -24.955 vs. CGC (-58.394). TEVA has higher annual earnings (EBITDA): 1.56B vs. CGC (-1.02B). TEVA has more cash in the bank: 3.23B vs. CGC (186M). CGC has less debt than TEVA: CGC (693M) vs TEVA (20.2B). TEVA has higher revenues than CGC: TEVA (15.8B) vs CGC (362M).
CGCTEVACGC / TEVA
Capitalization785M15.1B5%
EBITDA-1.02B1.56B-66%
Gain YTD-58.394-24.955234%
P/E RatioN/A22.62-
Revenue362M15.8B2%
Total Cash186M3.23B6%
Total Debt693M20.2B3%
FUNDAMENTALS RATINGS
CGC vs TEVA: Fundamental Ratings
CGC
TEVA
OUTLOOK RATING
1..100
955
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
69
Overvalued
PROFIT vs RISK RATING
1..100
10067
SMR RATING
1..100
9894
PRICE GROWTH RATING
1..100
9261
P/E GROWTH RATING
1..100
10013
SEASONALITY SCORE
1..100
595

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TEVA's Valuation (69) in the Pharmaceuticals Generic industry is in the same range as CGC (91) in the Agricultural Commodities Or Milling industry. This means that TEVA’s stock grew similarly to CGC’s over the last 12 months.

TEVA's Profit vs Risk Rating (67) in the Pharmaceuticals Generic industry is somewhat better than the same rating for CGC (100) in the Agricultural Commodities Or Milling industry. This means that TEVA’s stock grew somewhat faster than CGC’s over the last 12 months.

TEVA's SMR Rating (94) in the Pharmaceuticals Generic industry is in the same range as CGC (98) in the Agricultural Commodities Or Milling industry. This means that TEVA’s stock grew similarly to CGC’s over the last 12 months.

TEVA's Price Growth Rating (61) in the Pharmaceuticals Generic industry is in the same range as CGC (92) in the Agricultural Commodities Or Milling industry. This means that TEVA’s stock grew similarly to CGC’s over the last 12 months.

TEVA's P/E Growth Rating (13) in the Pharmaceuticals Generic industry is significantly better than the same rating for CGC (100) in the Agricultural Commodities Or Milling industry. This means that TEVA’s stock grew significantly faster than CGC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CGCTEVA
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
75%
Bearish Trend 3 days ago
72%
Momentum
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
76%
MACD
ODDS (%)
Bullish Trend 3 days ago
71%
Bullish Trend 3 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
72%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
67%
Advances
ODDS (%)
Bullish Trend 6 days ago
78%
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 12 days ago
73%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
84%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
60%
View a ticker or compare two or three
Interact to see
Advertisement
CGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TEVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DLQAX13.740.08
+0.59%
BNY Mellon Large Cap Equity A
LEGCX53.900.22
+0.41%
Columbia Large Cap Growth C
MCSSX40.500.15
+0.37%
NYLI WMC Enduring Capital Investor Class
GABAX50.060.17
+0.34%
Gabelli Asset AAA
IASMX18.58-0.16
-0.85%
Guinness Atkinson Asia Focus

TEVA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TEVA has been loosely correlated with AMRX. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if TEVA jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TEVA
1D Price
Change %
TEVA100%
-0.24%
AMRX - TEVA
38%
Loosely correlated
+0.75%
ELAN - TEVA
31%
Poorly correlated
+1.57%
VTRS - TEVA
30%
Poorly correlated
+0.64%
CGC - TEVA
26%
Poorly correlated
+2.70%
SNDL - TEVA
26%
Poorly correlated
-1.62%
More